Baird Financial Group, Inc. Intercept Pharmaceuticals, Inc. Transaction History

Baird Financial Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $33,950 - $66,913	-727 Reduced 10.49%	6,203 $769,000
Q1 2020 May 14, 2020	BUY	$48.35 - $118.68 $25,142 - $61,713	520 Added 8.11%	6,930 $436,000
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $16,462 - $35,616	-287 Reduced 4.29%	6,410 $794,000
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $200,132 - $274,368	3,410 Added 103.74%	6,697 $444,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $8,554 - $13,274	110 Added 3.46%	3,287 $262,000
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $291,743 - $383,400	3,177 New	3,177 $355,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.